KELLEY HASENAUER: Open Payments
NPI 1780699132 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 36 payments from 16 companies in 2025. Trend: 2023 $832 · 2024 $701 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $279 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Lundbeck LLC | 3 | $44 |
| Astellas Pharma US Inc | 1 | $34 |
| Novo Nordisk Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Biogen, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| BioWound Solutions, Inc. | 1 | $20 |
Products named: QULIPTA, REXULTI, UBRELVY, CAPLYTA, Veozah, Rybelsus, VRAYLAR, ZURZUVAE.
Industry payments across NE — which companies pay providers there.
